{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T20:04:59Z","timestamp":1791576299344,"version":"4.3.4"},"reference-count":149,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T00:00:00Z","timestamp":1750118400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82304348"],"award-info":[{"award-number":["82304348"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32060210"],"award-info":[{"award-number":["32060210"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82160813"],"award-info":[{"award-number":["82160813"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010265","name":"Guizhou Medical University","doi-asserted-by":"publisher","award":["[2024]011"],"award-info":[{"award-number":["[2024]011"]}],"id":[{"id":"10.13039\/501100010265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Analysis"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.jpha.2025.101372","type":"journal-article","created":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T11:15:28Z","timestamp":1750331728000},"page":"101372","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Exploring TGFBR3 in disease pathogenesis: Mechanisms, clinical implications, and pharmacological modulation"],"prefix":"10.1016","volume":"16","author":[{"given":"Hui","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinjiang","family":"Chou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meijun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jue","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojiang","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpha.2025.101372_bib1","doi-asserted-by":"crossref","first-page":"4001","DOI":"10.1073\/pnas.75.8.4001","article-title":"Growth factors from murine sarcoma virus-transformed cells","volume":"75","author":"de Larco","year":"1978","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jpha.2025.101372_bib2","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a022061","article-title":"TGF-\u03b2 signaling from receptors to Smads","volume":"8","author":"Hata","year":"2016","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.jpha.2025.101372_bib3","doi-asserted-by":"crossref","first-page":"4007","DOI":"10.1016\/j.cell.2023.07.036","article-title":"TGF-\u03b2 signaling in health and disease","volume":"186","author":"Massagu\u00e9","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.jpha.2025.101372_bib4","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/0092-8674(93)90368-Z","article-title":"Betaglycan presents ligand to the TGF beta signaling receptor","volume":"73","author":"L\u00f3pez-Casillas","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.jpha.2025.101372_bib5","doi-asserted-by":"crossref","first-page":"4371","DOI":"10.1128\/MCB.23.12.4371-4385.2003","article-title":"Heart and liver defects and reduced transforming growth factor beta2 sensitivity in transforming growth factor beta type III receptor-deficient embryos","volume":"23","author":"Stenvers","year":"2003","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.jpha.2025.101372_bib6","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1161\/CIRCRESAHA.107.152082","article-title":"Coronary vessel development is dependent on the type III transforming growth factor beta receptor","volume":"101","author":"Compton","year":"2007","journal-title":"Circ. Res."},{"key":"10.1016\/j.jpha.2025.101372_bib7","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1002\/dvg.22876","article-title":"Betaglycan knock-down causes embryonic angiogenesis defects in zebrafish","volume":"53","author":"Kamaid","year":"2015","journal-title":"Genesis"},{"key":"10.1016\/j.jpha.2025.101372_bib8","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/dvdy.393","article-title":"Chordacentrum mineralization is delayed in zebrafish betaglycan-null mutants","volume":"251","author":"Molina-Villa","year":"2022","journal-title":"Dev. Dyn."},{"key":"10.1016\/j.jpha.2025.101372_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1088039","article-title":"Transforming growth factor receptor III (Betaglycan) regulates the generation of pathogenic Th17 cells in EAE","volume":"14","author":"Duesman","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jpha.2025.101372_bib10","doi-asserted-by":"crossref","first-page":"D523","DOI":"10.1093\/nar\/gkac1052","article-title":"UniProt: The universal protein knowledgebase in 2023","volume":"51","year":"2023","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jpha.2025.101372_bib11","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s12943-022-01569-x","article-title":"Targeting TGF-\u03b2 signal transduction for fibrosis and cancer therapy","volume":"21","author":"Peng","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.jpha.2025.101372_bib12","doi-asserted-by":"crossref","first-page":"14588","DOI":"10.1074\/jbc.M008866200","article-title":"Ligand binding and functional properties of betaglycan, a co-receptor of the transforming growth factor-beta superfamily. Specialized binding regions for transforming growth factor-beta and inhibin A","volume":"276","author":"Esparza-Lopez","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jpha.2025.101372_bib13","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1074\/jbc.RA118.005210","article-title":"TGF-\u03b22 uses the concave surface of its extended finger region to bind betaglycan\u2019s ZP domain via three residues specific to TGF-\u03b2 and inhibin-\u03b1","volume":"294","author":"Henen","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jpha.2025.101372_bib14","doi-asserted-by":"crossref","first-page":"5927","DOI":"10.1016\/S0021-9258(18)42643-9","article-title":"Binding of two growth factor families to separate domains of the proteoglycan betaglycan","volume":"267","author":"Andres","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jpha.2025.101372_bib15","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.neo.2014.05.008","article-title":"The balance of cell surface and soluble type III TGF-\u03b2 receptor regulates BMP signaling in normal and cancerous mammary epithelial cells","volume":"16","author":"Gatza","year":"2014","journal-title":"Neoplasia"},{"key":"10.1016\/j.jpha.2025.101372_bib16","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/0092-8674(91)90073-8","article-title":"Structure and expression of the membrane proteoglycan betaglycan, a component of the TGF-beta receptor system","volume":"67","author":"L\u00f3pez-Casillas","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.jpha.2025.101372_bib17","doi-asserted-by":"crossref","first-page":"24627","DOI":"10.1074\/jbc.M100188200","article-title":"Functional roles for the cytoplasmic domain of the type III transforming growth factor beta receptor in regulating transforming growth factor beta signaling","volume":"276","author":"Blobe","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jpha.2025.101372_bib18","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1126\/science.1083195","article-title":"Beta-arrestin 2 mediates endocytosis of type III TGF-beta receptor and down-regulation of its signaling","volume":"301","author":"Chen","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.jpha.2025.101372_bib19","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1093\/carcin\/bgp071","article-title":"The type III transforming growth factor-beta receptor negatively regulates nuclear factor kappa B signaling through its interaction with beta-arrestin2","volume":"30","author":"You","year":"2009","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.jpha.2025.101372_bib20","doi-asserted-by":"crossref","first-page":"8221","DOI":"10.1073\/pnas.0812879106","article-title":"The type III TGF-beta receptor regulates epithelial and cancer cell migration through beta-arrestin2-mediated activation of Cdc42","volume":"106","author":"Mythreye","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jpha.2025.101372_bib21","doi-asserted-by":"crossref","first-page":"39608","DOI":"10.1074\/jbc.M106831200","article-title":"A novel mechanism for regulating transforming growth factor beta (TGF-beta) signaling. Functional modulation of type III TGF-beta receptor expression through interaction with the PDZ domain protein","volume":"276","author":"Blobe","year":"2001","journal-title":"GIPC, J. Biol. Chem."},{"key":"10.1016\/j.jpha.2025.101372_bib22","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/s41587-020-0546-8","article-title":"Visualizing and interpreting cancer genomics data via the Xena platform","volume":"38","author":"Goldman","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jpha.2025.101372_bib23","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.cellsig.2010.01.016","article-title":"Roles for the type III TGF-beta receptor in human cancer","volume":"22","author":"Gatza","year":"2010","journal-title":"Cell. Signal."},{"key":"10.1016\/j.jpha.2025.101372_bib24","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1593\/neo.11528","article-title":"Type III TGF-\u03b2 receptor enhances colon cancer cell migration and anchorage-independent growth","volume":"13","author":"Gatza","year":"2011","journal-title":"Neoplasia"},{"key":"10.1016\/j.jpha.2025.101372_bib25","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/iep.12380","article-title":"TGFBR3 is an independent unfavourable prognostic marker in oesophageal squamous cell cancer and is positively correlated with Ki-67","volume":"101","author":"Zhang","year":"2020","journal-title":"Int. J. Exp. Pathol."},{"key":"10.1016\/j.jpha.2025.101372_bib26","first-page":"200","article-title":"Soluble type III TGF\u03b2 receptor in diagnosis and follow-up of patients with breast cancer","volume":"33","author":"Jurisic","year":"2015","journal-title":"Growth Factors"},{"key":"10.1016\/j.jpha.2025.101372_bib27","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1172\/JCI29293","article-title":"The type III TGF-beta receptor suppresses breast cancer progression","volume":"117","author":"Dong","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jpha.2025.101372_bib28","doi-asserted-by":"crossref","first-page":"100","DOI":"10.3390\/cancers8110100","article-title":"T\u03b2RIII expression in human breast cancer stroma and the role of soluble T\u03b2RIII in breast cancer associated fibroblasts","volume":"8","author":"Jovanovi\u0107","year":"2016","journal-title":"Cancers"},{"key":"10.1016\/j.jpha.2025.101372_bib29","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/5548918","article-title":"Identification of hub genes to regulate breast cancer spinal metastases by bioinformatics analyses","volume":"2021","author":"He","year":"2021","journal-title":"Comput. Math. Methods Med."},{"key":"10.1016\/j.jpha.2025.101372_bib30","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.258396","article-title":"TGFBR3 supports anoikis through suppressing ATF4 signaling","volume":"135","author":"Hsu","year":"2022","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.jpha.2025.101372_bib31","doi-asserted-by":"crossref","first-page":"3541","DOI":"10.1038\/sj.onc.1205439","article-title":"Extracellular domain of TGFbeta type III receptor inhibits angiogenesis and tumor growth in human cancer cells","volume":"21","author":"Bandyopadhyay","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.jpha.2025.101372_bib32","doi-asserted-by":"crossref","first-page":"7514","DOI":"10.1038\/sj.onc.1205966","article-title":"Autocrine TGFbeta supports growth and survival of human breast cancer MDA-MB-231 cells","volume":"21","author":"Lei","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.jpha.2025.101372_bib33","doi-asserted-by":"crossref","first-page":"25367","DOI":"10.1074\/jbc.272.40.25367","article-title":"Expression of transforming growth factor beta type III receptor suppresses tumorigenicity of human breast cancer MDA-MB-231 cells","volume":"272","author":"Sun","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jpha.2025.101372_bib34","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.1172\/JCI65745","article-title":"Type III TGF-\u03b2 receptor downregulation generates an immunotolerant tumor microenvironment","volume":"123","author":"Hanks","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jpha.2025.101372_bib35","doi-asserted-by":"crossref","DOI":"10.1186\/bcr3684","article-title":"Transforming growth factor beta receptor type III is a tumor promoter in mesenchymal-stem like triple negative breast cancer","volume":"16","author":"Jovanovi\u0107","year":"2014","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.jpha.2025.101372_bib36","doi-asserted-by":"crossref","first-page":"7304","DOI":"10.1158\/0008-5472.CAN-07-6777","article-title":"Knockdown of the transforming growth factor-beta type III receptor impairs motility and invasion of metastatic cancer cells","volume":"68","author":"Criswell","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.jpha.2025.101372_bib37","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1158\/0008-5472.CAN-06-3117","article-title":"The type III transforming growth factor-beta receptor as a novel tumor suppressor gene in prostate cancer","volume":"67","author":"Turley","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.jpha.2025.101372_bib38","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1158\/0008-5472.CAN-17-1051","article-title":"Osteoblast-secreted factors mediate dormancy of metastatic prostate cancer in the bone via activation of the TGF\u03b2RIII-p38MAPK-pS249\/T252RB pathway","volume":"78","author":"Yu-Lee","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.jpha.2025.101372_bib39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0260983","article-title":"Prediction of potential prognostic biomarkers in metastatic prostate cancer based on a circular RNA-mediated competing endogenous RNA regulatory network","volume":"16","author":"Luo","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.jpha.2025.101372_bib40","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/pros.20166","article-title":"Systemic administration of a soluble betaglycan suppresses tumor growth, angiogenesis, and matrix metalloproteinase-9 expression in a human xenograft model of prostate cancer","volume":"63","author":"Bandyopadhyay","year":"2005","journal-title":"Prostate"},{"key":"10.1016\/j.jpha.2025.101372_bib41","doi-asserted-by":"crossref","first-page":"6959","DOI":"10.1038\/s41388-019-0913-4","article-title":"Betaglycan drives the mesenchymal stromal cell osteogenic program and prostate cancer-induced osteogenesis","volume":"38","author":"Cook","year":"2019","journal-title":"Oncogene"},{"key":"10.1016\/j.jpha.2025.101372_bib42","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1038\/s41388-017-0084-0","article-title":"Decreased TGFBR3\/betaglycan expression enhances the metastatic abilities of renal cell carcinoma cells through TGF-\u03b2-dependent and -independent mechanisms","volume":"37","author":"Nishida","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.jpha.2025.101372_bib43","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1093\/carcin\/bgm249","article-title":"Loss of type III transforming growth factor beta receptor expression increases motility and invasiveness associated with epithelial to mesenchymal transition during pancreatic cancer progression","volume":"29","author":"Gordon","year":"2008","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.jpha.2025.101372_bib44","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1093\/carcin\/bgn274","article-title":"Bone morphogenetic proteins induce pancreatic cancer cell invasiveness through a Smad1-dependent mechanism that involves matrix metalloproteinase-2","volume":"30","author":"Gordon","year":"2009","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.jpha.2025.101372_bib45","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/cam4.3627","article-title":"HELLS, a chromatin remodeler is highly expressed in pancreatic cancer and downregulation of it impairs tumor growth and sensitizes to cisplatin by reexpressing the tumor suppressor TGFBR3","volume":"10","author":"Hou","year":"2021","journal-title":"Cancer Med"},{"key":"10.1016\/j.jpha.2025.101372_bib46","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1093\/carcin\/bgm289","article-title":"TbetaRIII suppresses non-small cell lung cancer invasiveness and tumorigenicity","volume":"29","author":"Finger","year":"2008","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.jpha.2025.101372_bib47","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/6663990","article-title":"Abnormal expression and prognostic significance of bone morphogenetic proteins and their receptors in lung adenocarcinoma","volume":"2021","author":"Xu","year":"2021","journal-title":"Biomed Res. Int."},{"key":"10.1016\/j.jpha.2025.101372_bib48","first-page":"5263","article-title":"Low expression of INHB co-receptor TGFBR3 in connection with metastasis and immune infiltration in lung adenocarcinoma","volume":"14","author":"Zou","year":"2022","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.jpha.2025.101372_bib49","doi-asserted-by":"crossref","first-page":"196","DOI":"10.2478\/ams-2013-0025","article-title":"Molecular profiles of non-small cell lung cancers in cigarette smoking and never-smoking patients","volume":"58","author":"Szymanowska-Narloch","year":"2013","journal-title":"Adv. Med. Sci."},{"key":"10.1016\/j.jpha.2025.101372_bib50","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1002\/iub.1752","article-title":"Upregulated lncRNA ADAMTS9-AS2 suppresses progression of lung cancer through inhibition of miR-223-3p and promotion of TGFBR3","volume":"70","author":"Liu","year":"2018","journal-title":"IUBMB Life"},{"key":"10.1016\/j.jpha.2025.101372_bib51","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1158\/1940-6207.CAPR-10-0170","article-title":"A gene expression signature from peripheral whole blood for stage I lung adenocarcinoma","volume":"4","author":"Rotunno","year":"2011","journal-title":"Cancer Prev. Res. (Phila)"},{"key":"10.1016\/j.jpha.2025.101372_bib52","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.1038\/s41388-018-0672-7","article-title":"Increased type III TGF-\u03b2 receptor shedding decreases tumorigenesis through induction of epithelial-to-mesenchymal transition","volume":"38","author":"Huang","year":"2019","journal-title":"Oncogene"},{"key":"10.1016\/j.jpha.2025.101372_bib53","first-page":"475","article-title":"Down-regulation of transforming growth factor beta receptor type III in hepatocellular carcinoma is not directly associated with genetic alterations or loss of heterozygosity","volume":"22","author":"Bae","year":"2009","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.jpha.2025.101372_bib54","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.3892\/or.2016.4615","article-title":"Decreased expression of the type III TGF-\u03b2 receptor enhances metastasis and invasion in hepatocellullar carcinoma progression","volume":"35","author":"Zhang","year":"2016","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.jpha.2025.101372_bib55","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.3390\/cancers12061375","article-title":"The tumor suppressor TGFBR3 blocks lymph node metastasis in head and neck cancer","volume":"12","author":"Fang","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jpha.2025.101372_bib56","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/1471-2407-11-88","article-title":"Downregulation of TGF-beta receptor types II and III in oral squamous cell carcinoma and oral carcinoma-associated fibroblasts","volume":"11","author":"Meng","year":"2011","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jpha.2025.101372_bib57","doi-asserted-by":"crossref","first-page":"790","DOI":"10.3389\/fendo.2019.00790","article-title":"Identification of a five-gene signature and establishment of a prognostic nomogram to predict progression-free interval of papillary thyroid carcinoma","volume":"10","author":"Wu","year":"2019","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.jpha.2025.101372_bib58","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0259534","article-title":"Prognostic biomarkers for predicting papillary thyroid carcinoma patients at high risk using nine genes of apoptotic pathway","volume":"16","author":"Arora","year":"2021","journal-title":"PloS One"},{"key":"10.1016\/j.jpha.2025.101372_bib59","article-title":"Using tumor-infiltrating immune cells and a ceRNA network model to construct a prognostic analysis model of thyroid carcinoma","volume":"11","author":"Zhang","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.jpha.2025.101372_bib60","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.2147\/IJGM.S346058","article-title":"Identification of a four-gene signature for determining the prognosis of papillary thyroid carcinoma by integrated bioinformatics analysis","volume":"15","author":"Luo","year":"2022","journal-title":"Int. J. Gen. Med."},{"key":"10.1016\/j.jpha.2025.101372_bib61","doi-asserted-by":"crossref","first-page":"R84","DOI":"10.1186\/gb-2006-7-9-r84","article-title":"Human fetal neuroblast and neuroblastoma transcriptome analysis confirms neuroblast origin and highlights neuroblastoma candidate genes","volume":"7","author":"De Preter","year":"2006","journal-title":"Genome Biol"},{"key":"10.1016\/j.jpha.2025.101372_bib62","doi-asserted-by":"crossref","first-page":"4786","DOI":"10.1172\/JCI69657","article-title":"Type III TGF-\u03b2 receptor promotes FGF2-mediated neuronal differentiation in neuroblastoma","volume":"123","author":"Knelson","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jpha.2025.101372_bib63","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.jpha.2025.101372_bib64","first-page":"519M","article-title":"Metastatic breast cancer, Radiol","volume":"88","author":"Peart","year":"2017","journal-title":"Technol."},{"key":"10.1016\/j.jpha.2025.101372_bib65","article-title":"Ionizing radiation and estrogen affecting growth factor genes in an experimental breast cancer model","volume":"23","author":"Calaf","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jpha.2025.101372_bib66","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/carcin\/bgp271","article-title":"The type III TGF-beta receptor suppresses breast cancer progression through GIPC-mediated inhibition of TGF-beta signaling","volume":"31","author":"Lee","year":"2010","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.jpha.2025.101372_bib67","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1091\/mbc.e13-09-0524","article-title":"Ectodomain shedding of T\u03b2RIII is required for T\u03b2RIII-mediated suppression of TGF-\u03b2 signaling and breast cancer migration and invasion","volume":"25","author":"Elderbroom","year":"2014","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.jpha.2025.101372_bib68","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1091\/mbc.e14-03-0825","article-title":"Role of TGF-\u03b2 receptor III localization in polarity and breast cancer progression","volume":"25","author":"Meyer","year":"2014","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.jpha.2025.101372_bib69","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1186\/s12943-024-02156-y","article-title":"Regulatory T cells in immune checkpoint blockade antitumor therapy","volume":"23","author":"Zhang","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.jpha.2025.101372_bib70","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41572-020-00243-0","article-title":"Prostate cancer","volume":"7","author":"Rebello","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.jpha.2025.101372_bib71","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s10555-017-9719-4","article-title":"Current perspectives on bone metastases in castrate-resistant prostate cancer","volume":"37","author":"Logothetis","year":"2018","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.jpha.2025.101372_bib72","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1158\/1541-7786.MCR-22-0099","article-title":"Molecular profile changes in patients with castrate-resistant prostate cancer pre- and post-abiraterone\/prednisone treatment","volume":"20","author":"Sicotte","year":"2022","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.jpha.2025.101372_bib73","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2017.9","article-title":"Renal cell carcinoma","volume":"3","author":"Hsieh","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.jpha.2025.101372_bib74","first-page":"179","article-title":"Renal cell carcinoma: Diagnosis and management","volume":"99","author":"Gray","year":"2019","journal-title":"Am. Fam. Physician"},{"key":"10.1016\/j.jpha.2025.101372_bib75","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/JU.0000000000001912","article-title":"Renal mass and localized renal cancer: Evaluation, management, and follow-up: AUA guideline: Part II","volume":"206","author":"Campbell","year":"2021","journal-title":"J. Urol."},{"key":"10.1016\/j.jpha.2025.101372_bib76","doi-asserted-by":"crossref","first-page":"8053","DOI":"10.1038\/sj.onc.1206835","article-title":"Genomic profiling identifies alterations in TGFbeta signaling through loss of TGFbeta receptor expression in human renal cell carcinogenesis and progression","volume":"22","author":"Copland","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.jpha.2025.101372_bib77","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1038\/onc.2010.64","article-title":"Loss of type III transforming growth factor-beta receptor expression is due to methylation silencing of the transcription factor GATA3 in renal cell carcinoma","volume":"29","author":"Cooper","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.jpha.2025.101372_bib78","article-title":"Development of a TGF-\u03b2 signaling-related genes signature to predict clinical prognosis and immunotherapy responses in clear cell renal cell carcinoma","volume":"13","author":"Wu","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.jpha.2025.101372_bib79","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1158\/1078-0432.CCR-20-4504","article-title":"Angiokines associated with targeted therapy outcomes in patients with non-clear cell renal cell carcinoma","volume":"27","author":"Armstrong","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jpha.2025.101372_bib80","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/S2468-1253(19)30347-4","article-title":"The global, regional, and national burden of pancreatic cancer and its attributable risk factors in 195 countries and territories, 1990-2017: A systematic analysis for the Global Burden of Disease Study 2017","volume":"4","year":"2019","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.jpha.2025.101372_bib81","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1016\/S0140-6736(20)30974-0","article-title":"Pancreatic cancer","volume":"395","author":"Mizrahi","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jpha.2025.101372_bib82","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13046-018-0697-3","article-title":"microRNA-193a stimulates pancreatic cancer cell repopulation and metastasis through modulating TGF-\u03b22\/TGF-\u03b2RIII signalings","volume":"37","author":"Fang","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.jpha.2025.101372_bib83","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1186\/s13046-019-1313-x","article-title":"Macrophage-derived exosomal microRNA-501-3p promotes progression of pancreatic ductal adenocarcinoma through the TGFBR3-mediated TGF-\u03b2 signaling pathway","volume":"38","author":"Yin","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.jpha.2025.101372_bib84","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1158\/1055-9965.EPI-19-0221","article-title":"Cancer progress and priorities: Lung cancer","volume":"28","author":"Schabath","year":"2019","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.jpha.2025.101372_bib85","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s00281-016-0592-y","article-title":"The role of dendritic cells in cancer","volume":"39","author":"Hansen","year":"2017","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.jpha.2025.101372_bib86","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1158\/2326-6066.CIR-19-0574","article-title":"CD4+ T-cell immunity in the peripheral blood correlates with response to anti-PD-1 therapy","volume":"8","author":"Kagamu","year":"2020","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.jpha.2025.101372_bib87","first-page":"1013","article-title":"Bone morphogenetic protein 2 inhibits the proliferation and growth of human colorectal cancer cells, Oncol","volume":"32","author":"Zhang","year":"2014","journal-title":"Rep."},{"key":"10.1016\/j.jpha.2025.101372_bib88","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1245\/s10434-007-9746-4","article-title":"Clinical significance of BMP7 in human colorectal cancer","volume":"15","author":"Motoyama","year":"2008","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.jpha.2025.101372_bib89","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1002\/ar.22802","article-title":"TGFBR3 co-downregulated with GATA3 is associated with methylation of the GATA3 gene in bladder urothelial carcinoma","volume":"296","author":"Liu","year":"2013","journal-title":"Anat. Rec. (Hoboken)"},{"key":"10.1016\/j.jpha.2025.101372_bib90","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.3892\/or.2013.2599","article-title":"Dual role of TGFBR3 in bladder cancer","volume":"30","author":"Liu","year":"2013","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.jpha.2025.101372_bib91","doi-asserted-by":"crossref","first-page":"542","DOI":"10.2119\/2007-00034.Bellucci","article-title":"Differences in extracellular matrix production and basic fibroblast growth factor response in skin fibroblasts from sporadic and familial Alzheimer\u2019s disease","volume":"13","author":"Bellucci","year":"2007","journal-title":"Mol. Med."},{"key":"10.1016\/j.jpha.2025.101372_bib92","doi-asserted-by":"crossref","DOI":"10.12659\/MSM.919311","article-title":"Related network and differential expression analyses identify nuclear genes and pathways in the hippocampus of Alzheimer disease","volume":"26","author":"Quan","year":"2020","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.jpha.2025.101372_bib93","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.825729","article-title":"Promoter hypomethylation of TGFBR3 as a risk factor of Alzheimer\u2019s disease: An integrated epigenomic-transcriptomic analysis","volume":"9","author":"Song","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.jpha.2025.101372_bib94","doi-asserted-by":"crossref","first-page":"7706","DOI":"10.1007\/s12035-025-04731-w","article-title":"Overexpression of TGFBR3 aggravates cognitive impairment and neuroinflammation by promoting microglia M1 polarization in the APP\/PS1 mouse model of Alzheimer\u2019s disease","volume":"62","author":"Song","year":"2025","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.jpha.2025.101372_bib95","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1002\/glia.24606","article-title":"Soluble TGF-\u03b2 decoy receptor TGFBR3 exacerbates Alzheimer's disease pathology by modifying microglial function","volume":"72","author":"Zhou","year":"2024","journal-title":"Glia"},{"key":"10.1016\/j.jpha.2025.101372_bib96","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00401-020-02196-w","article-title":"The physiological roles of tau and A\u03b2: implications for Alzheimer\u2019s disease pathology and therapeutics","volume":"140","author":"Kent","year":"2020","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jpha.2025.101372_bib97","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.bbamcr.2010.12.005","article-title":"The type III TGF-\u03b2 receptor betaglycan transmembrane-cytoplasmic domain fragment is stable after ectodomain cleavage and is a substrate of the intramembrane protease \u03b3-secretase","volume":"1813","author":"Blair","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jpha.2025.101372_bib99","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1097\/HJH.0000000000002958","article-title":"Global burden of cardiovascular diseases attributable to hypertension in young adults from 1990 to 2019","volume":"39","author":"Liu","year":"2021","journal-title":"J. Hypertens."},{"key":"10.1016\/j.jpha.2025.101372_bib100","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ydbio.2011.08.008","article-title":"The cytoplasmic domain of TGF\u03b2R3 through its interaction with the scaffolding protein, GIPC, directs epicardial cell behavior","volume":"358","author":"S\u00e1nchez","year":"2011","journal-title":"Dev. Biol."},{"key":"10.1016\/j.jpha.2025.101372_bib101","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.ebiom.2019.08.001","article-title":"MicroRNA let-7-TGFBR3 signalling regulates cardiomyocyte apoptosis after infarction","volume":"46","author":"Chen","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.jpha.2025.101372_bib102","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.863248","article-title":"Systematic bioinformatics analysis based on public and second-generation sequencing transcriptome data: A study on the diagnostic value and potential mechanisms of immune-related genes in acute myocardial infarction","volume":"9","author":"Tan","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.jpha.2025.101372_bib103","doi-asserted-by":"crossref","first-page":"6693","DOI":"10.1007\/s11033-020-05723-w","article-title":"Probing the epigenetic signatures in subjects with coronary artery disease","volume":"47","author":"Indumathi","year":"2020","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.jpha.2025.101372_bib104","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.gene.2014.02.034","article-title":"Genome wide DNA methylation profiling for epigenetic alteration in coronary artery disease patients","volume":"541","author":"Sharma","year":"2014","journal-title":"Gene"},{"key":"10.1016\/j.jpha.2025.101372_bib105","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1126\/science.283.5410.2080","article-title":"Requirement of type III TGF-beta receptor for endocardial cell transformation in the heart","volume":"283","author":"Brown","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.jpha.2025.101372_bib106","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.cellsig.2011.10.006","article-title":"TGF\u03b2 and BMP-2 regulate epicardial cell invasion via TGF\u03b2R3 activation of the Par6\/Smurf1\/RhoA pathway","volume":"24","author":"S\u00e1nchez","year":"2012","journal-title":"Cell. Signal."},{"key":"10.1016\/j.jpha.2025.101372_bib107","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.cellsig.2014.11.037","article-title":"Type III TGF\u03b2 receptor and Src direct hyaluronan-mediated invasive cell motility","volume":"27","author":"Allison","year":"2015","journal-title":"Cell. Signal."},{"key":"10.1016\/j.jpha.2025.101372_bib108","doi-asserted-by":"crossref","unstructured":"D.M. DeLaughter, C.R. Clark, D.C. Christodoulou, et al., Transcriptional profiling of cultured, embryonic epicardial cells identifies novel genes and signaling pathways regulated by TGF\u03b2R3 in vitro, PLoS One 11 (2016), e0159710.","DOI":"10.1371\/journal.pone.0159710"},{"key":"10.1016\/j.jpha.2025.101372_bib109","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.cellsig.2011.09.006","article-title":"Endocardial cell epithelial-mesenchymal transformation requires Type III TGF\u03b2 receptor interaction with GIPC","volume":"24","author":"Townsend","year":"2012","journal-title":"Cell. Signal."},{"key":"10.1016\/j.jpha.2025.101372_bib110","doi-asserted-by":"crossref","first-page":"13567","DOI":"10.1074\/jbc.270.22.13567","article-title":"Expression of transforming growth factor type III receptor in vascular endothelial cells increases their responsiveness to transforming growth factor \u03b22","volume":"270","author":"Sankar","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jpha.2025.101372_bib111","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1002\/jcp.22604","article-title":"TGFBR3, a potential negative regulator of TGF-\u03b2 signaling, protects cardiac fibroblasts from hypoxia-induced apoptosis","volume":"226","author":"Chu","year":"2011","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.jpha.2025.101372_bib112","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1093\/cvr\/cvn315","article-title":"A synthetic peptide from transforming growth factor-beta1 type III receptor prevents myocardial fibrosis in spontaneously hypertensive rats","volume":"81","author":"Hermida","year":"2009","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.jpha.2025.101372_bib113","doi-asserted-by":"crossref","first-page":"e440","DOI":"10.1161\/ATVBAHA.121.316496","article-title":"Anti-TGF\u03b2 (transforming growth factor \u03b2) therapy with betaglycan-derived P144 peptide gene delivery prevents the formation of aortic aneurysm in a mouse model of Marfan syndrome","volume":"41","author":"Arce","year":"2021","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.jpha.2025.101372_bib114","doi-asserted-by":"crossref","first-page":"3779","DOI":"10.1111\/bph.13166","article-title":"Simvastatin alleviates cardiac fibrosis induced by infarction via up-regulation of TGF-\u03b2 receptor III expression","volume":"172","author":"Sun","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jpha.2025.101372_bib115","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1016\/j.biocel.2012.08.019","article-title":"A novel reciprocal loop between microRNA-21 and TGF\u03b2RIII is involved in cardiac fibrosis","volume":"44","author":"Liang","year":"2012","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.jpha.2025.101372_bib116","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1159\/000447793","article-title":"MicroRNA-328, a potential anti-fibrotic target in cardiac interstitial fibrosis","volume":"39","author":"Du","year":"2016","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.jpha.2025.101372_bib117","doi-asserted-by":"crossref","first-page":"3246","DOI":"10.1111\/jcmm.14211","article-title":"Novel role of the clustered miR-23b-3p and miR-27b-3p in enhanced expression of fibrosis-associated genes by targeting TGFBR3 in atrial fibroblasts","volume":"23","author":"Yang","year":"2019","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.jpha.2025.101372_bib118","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2021.109119","article-title":"IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045","volume":"183","author":"Sun","year":"2022","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.jpha.2025.101372_bib119","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.21037\/atm-20-5647","article-title":"Investigation of hub genes involved in diabetic nephropathy using biological informatics methods","volume":"8","author":"Li","year":"2020","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.jpha.2025.101372_bib120","doi-asserted-by":"crossref","first-page":"6871","DOI":"10.2147\/JIR.S341032","article-title":"Identifying potential diagnostic genes for diabetic nephropathy based on hypoxia and immune status","volume":"14","author":"Li","year":"2021","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.jpha.2025.101372_bib121","doi-asserted-by":"crossref","first-page":"15715","DOI":"10.1074\/jbc.C300430200","article-title":"Syndecan-2 regulates transforming growth factor-beta signaling","volume":"279","author":"Chen","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jpha.2025.101372_bib122","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1073\/pnas.90.5.1814","article-title":"Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy","volume":"90","author":"Yamamoto","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jpha.2025.101372_bib123","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1159\/000065020","article-title":"Transforming growth factor-beta-1 latency-associated peptide and soluble betaglycan prevent a glucose-induced increase in fibronectin production in cultured human mesangial cells","volume":"91","author":"Nomura","year":"2002","journal-title":"Nephron"},{"key":"10.1016\/j.jpha.2025.101372_bib124","doi-asserted-by":"crossref","first-page":"F321","DOI":"10.1152\/ajprenal.00264.2006","article-title":"Soluble betaglycan reduces renal damage progression in db\/db mice","volume":"292","author":"Ju\u00e1rez","year":"2007","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.jpha.2025.101372_bib125","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/nature02759","article-title":"The challenge of emerging and re-emerging infectious diseases","volume":"430","author":"Morens","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.jpha.2025.101372_bib126","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1097\/MOP.0000000000001176","article-title":"Host-directed immunotherapy to fight infectious diseases","volume":"34","author":"Langelier","year":"2022","journal-title":"Curr. Opin. Pediatr."},{"key":"10.1016\/j.jpha.2025.101372_bib127","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1365-2249.2006.03049.x","article-title":"A combination of a transforming growth factor-beta antagonist and an inhibitor of cyclooxygenase is an effective treatment for murine pulmonary tuberculosis","volume":"144","author":"Hern\u00e1ndez-Pando","year":"2006","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jpha.2025.101372_bib128","doi-asserted-by":"crossref","first-page":"5128","DOI":"10.1038\/s41598-022-09175-z","article-title":"Identification of hub genes for adult patients with sepsis via RNA sequencing","volume":"12","author":"Zhang","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jpha.2025.101372_bib129","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1186\/s12890-022-02091-y","article-title":"LncRNA H19 alleviates sepsis-induced acute lung injury by regulating the miR-107\/TGFBR3 axis","volume":"22","author":"Hao","year":"2022","journal-title":"BMC Pulm. Med."},{"key":"10.1016\/j.jpha.2025.101372_bib130","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1159\/000327559","article-title":"TGFBR3 polymorphisms and its haplotypes associated with chronic hepatitis B virus infection and age of hepatocellular carcinoma occurrence","volume":"29","author":"Kim","year":"2011","journal-title":"Dig. Dis."},{"key":"10.1016\/j.jpha.2025.101372_bib131","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.jhep.2019.10.029","article-title":"A schistosome miRNA promotes host hepatic fibrosis by targeting transforming growth factor beta receptor III","volume":"72","author":"He","year":"2020","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jpha.2025.101372_bib132","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s12013-010-9140-x","article-title":"CREB5 computational regulation network construction and analysis between frontal cortex of HIV encephalitis (HIVE) and HIVE-control patients","volume":"60","author":"Wang","year":"2011","journal-title":"Cell Biochem. Biophys."},{"key":"10.1016\/j.jpha.2025.101372_bib133","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/00002030-199805000-00009","article-title":"Role of transforming growth factor-beta1 in the suppressed allostimulatory function of AIDS patients","volume":"12","author":"Brooks","year":"1998","journal-title":"AIDS"},{"key":"10.1016\/j.jpha.2025.101372_bib134","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S1043-4666(03)00101-7","article-title":"A synthetic peptide from transforming growth factor beta type III receptor inhibits liver fibrogenesis in rats with carbon tetrachloride liver injury","volume":"22","author":"Ezquerro","year":"2003","journal-title":"Cytokine"},{"key":"10.1016\/j.jpha.2025.101372_bib135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0096799","article-title":"Harnessing high density lipoproteins to block transforming growth factor beta and to inhibit the growth of liver tumor metastases","volume":"9","author":"Medina-Echeverz","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jpha.2025.101372_bib136","doi-asserted-by":"crossref","first-page":"5231","DOI":"10.1158\/0008-5472.CAN-07-0035","article-title":"Loss of betaglycan expression in ovarian cancer: Role in motility and invasion","volume":"67","author":"Hempel","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.jpha.2025.101372_bib137","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.bbrc.2023.07.037","article-title":"CUL4B enhances the malignant phenotype of esophageal squamous cell carcinoma by suppressing TGFBR3 expression","volume":"676","author":"Gong","year":"2023","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jpha.2025.101372_bib138","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109365","article-title":"Hsa_circ_0042666 inhibits proliferation and invasion via regulating miR-223\/TGFBR3 axis in laryngeal squamous cell carcinoma","volume":"119","author":"Wei","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jpha.2025.101372_bib139","doi-asserted-by":"crossref","first-page":"3262","DOI":"10.1074\/jbc.M113.541052","article-title":"Glucocorticoids recruit Tgfbr3 and Smad1 to shift transforming growth factor-\u03b2 signaling from the Tgfbr1\/Smad2\/3 axis to the Acvrl1\/Smad1 axis in lung fibroblasts","volume":"289","author":"Schwartze","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jpha.2025.101372_bib140","doi-asserted-by":"crossref","first-page":"587","DOI":"10.2337\/db18-0955","article-title":"Impaired glucocorticoid suppression of TGF\u03b2 signaling in human omental adipose tissues limits adipogenesis and may promote fibrosis","volume":"68","author":"Lee","year":"2019","journal-title":"Diabetes"},{"key":"10.1016\/j.jpha.2025.101372_bib141","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.bcp.2005.07.001","article-title":"N-acetyl-L-cysteine suppresses TGF-beta signaling at distinct molecular steps: The biochemical and biological efficacy of a multifunctional, antifibrotic drug","volume":"70","author":"Meurer","year":"2005","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jpha.2025.101372_bib142","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/pr.2017.21","article-title":"Caffeine administration modulates TGF-\u03b2 signaling but does not attenuate blunted alveolarization in a hyperoxia-based mouse model of bronchopulmonary dysplasia","volume":"81","author":"Rath","year":"2017","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.jpha.2025.101372_bib143","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/jat.1142","article-title":"Modulation of different stress pathways after styrene and styrene-7,8-oxide exposure in HepG2 cell line and normal human hepatocytes","volume":"26","author":"Diodovich","year":"2006","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.jpha.2025.101372_bib144","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/cmi.2015.73","article-title":"Retinoic acid enhances lactoferrin-induced IgA responses by increasing betaglycan expression","volume":"13","author":"Lee","year":"2016","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.jpha.2025.101372_bib145","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1002\/tox.22453","article-title":"Ouabain impairs cell migration, and invasion and alters gene expression of human osteosarcoma U-2 OS cells","volume":"32","author":"Shih","year":"2017","journal-title":"Environ. Toxicol."},{"key":"10.1016\/j.jpha.2025.101372_bib146","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.biopha.2007.10.016","article-title":"Toremifene decreases type I, type II and increases type III receptors in desmoid and fibroma and inhibits TGFbeta1 binding in desmoid fibroblasts","volume":"62","author":"Stabellini","year":"2008","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jpha.2025.101372_bib147","doi-asserted-by":"crossref","first-page":"3379","DOI":"10.1210\/en.2004-1665","article-title":"Effect of follicle-stimulating hormone and estrogen on the expression of betaglycan messenger ribonucleic acid levels in cultured rat granulosa cells","volume":"146","author":"Omori","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.jpha.2025.101372_bib148","first-page":"165","article-title":"The effects of indomethacin on angiogenic factors mRNA expression in renal cortex of healthy rats","volume":"58","author":"Mucha","year":"2007","journal-title":"J. Physiol. Pharmacol."},{"key":"10.1016\/j.jpha.2025.101372_bib149","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1530\/REP-06-0179","article-title":"Gonadotrophins modulate hormone secretion and steady-state mRNA levels for activin receptors (type I, IIA, IIB) and inhibin co-receptor (betaglycan) in granulosa and theca cells from chicken prehierarchical and preovulatory follicles","volume":"133","author":"Lovell","year":"2007","journal-title":"Reproduction"},{"key":"10.1016\/j.jpha.2025.101372_bib150","first-page":"929","article-title":"Down-regulation of transforming growth factor beta receptors by androgen in ovarian cancer cells","volume":"60","author":"Evangelou","year":"2000","journal-title":"Cancer Res"}],"container-title":["Journal of Pharmaceutical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2095177925001893?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2095177925001893?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T20:37:43Z","timestamp":1776371863000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2095177925001893"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":149,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S2095177925001893"],"URL":"https:\/\/doi.org\/10.1016\/j.jpha.2025.101372","relation":{},"ISSN":["2095-1779"],"issn-type":[{"value":"2095-1779","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring TGFBR3 in disease pathogenesis: Mechanisms, clinical implications, and pharmacological modulation","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpha.2025.101372","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V. on behalf of Xi\u2019an Jiaotong University.","name":"copyright","label":"Copyright"}],"article-number":"101372"}}